{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-118805","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.507495+00:00","generated_at":"2026-05-21T15:09:57.757385+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CytomX nets $93.4M in underwritten common stock offering; 76.9M shares at $1.30","bullets":["Sold 76,923,076 shares of common stock at $1.30/share, generating ~$93.4M in net proceeds after underwriting discounts and expenses.","Proceeds to be used for research and development, general corporate purposes, and working capital.","Underwriting syndicate led by Jefferies and Piper Sandler & Co.","Offering closed on May 13, 2025; shares issued under effective shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-118805","json":"https://secwatch.observer/filing/0001193125-25-118805.json","markdown":"https://secwatch.observer/filing/0001193125-25-118805.md","text":"https://secwatch.observer/filing/0001193125-25-118805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525118805/0001193125-25-118805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525118805/d53772d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T15:09:57.757385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}